Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01384266 · ClinicalTrials.gov registry record
A Comparison of 0.5% Loteprednol Etabonate Versus 1% Prednisolone Acetate Following Cataract Surgery
A clinical trial of Intraocular Inflammation, sponsored by Associated Eye Care, Minnesota.
- Completed
- Registry status
- 90
- Enrollment target
- 2
- Study locations
NCT01384266 is a study of Intraocular Inflammation that has completed, run by Associated Eye Care, Minnesota. The registered enrollment target is 90 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT01384266, a study of Intraocular Inflammation, has completed, sponsored by Associated Eye Care, Minnesota.
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
- 2
- Study locations
Study Summary
Patients are routinely given steroid eye drops following cataract surgery. This study will compare 2 approved drops:Loteprednol Etabonate versus Prednisolone Acetate Eye drops used following cataract surgery. Patients will be randomly assigned to one drop or the other, and evaluated for inflammation and intraocular pressure as part of the comparison. The study Doctor will be masked as to which drop the patient receives to avoid bias.
Conditions Studied
Study Locations (2)
Kentucky
- Cincinnati Eye Institute - Edgewood
Minnesota
- Associated Eye Care - Stillwater
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2010-05 |
| Est. Completion | 2011-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01384266
The ClinicalTrials.gov registry entry for NCT01384266 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Associated Eye Care, Minnesota, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Intraocular Inflammation appearing as the primary indexed condition, and to 0 interventions.
NCT01384266 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Kentucky, Minnesota.
Frequently Asked Questions
What is clinical trial NCT01384266 about?
NCT01384266 is a clinical study titled "A Comparison of 0.5% Loteprednol Etabonate Versus 1% Prednisolone Acetate Following Cataract Surgery". Patients are routinely given steroid eye drops following cataract surgery. This study will compare 2 approved drops:Loteprednol Etabonate versus Prednisolone Acetate Eye drops used following cataract surgery. Patients will be randomly assigned to one drop or the other, and evaluated for inflammation...
What is the current status of trial NCT01384266?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2010-05. Estimated completion is 2011-11.
What conditions does trial NCT01384266 study?
This clinical trial studies the following conditions: Intraocular Inflammation.
Who is sponsoring clinical trial NCT01384266?
This trial is sponsored by Associated Eye Care, Minnesota, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01384266 being conducted?
This trial has 2 study locations across Kentucky, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.